Dr.Gopal Munjal, chairman of pharma player, Ind Swift, joins CNBC-TV18 to give an outlook to his business and the industry. Ind Swift is restructuring and the management is confident of maintaining growth at 30% at year-end.
first published: Sep 14, 2011 03:09 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty breaks below 26,200 on expiry day, broader markets underperform | Closing Bell
Live: Will Nifty's weakness continue for the second straight day? | Opening Bell
A money superpower you have in your 20s, not in 40s
Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell
